New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
10:02 EDTAPA, BBW, UHS, MYGN, LPNT, HCA, CMI, THC, SCSC, WLH, OKS, FBRC, YELP, TPVG, MELI, AMZG, CYH, DRC, NGLS, KSOn The Fly: Analyst Initiation Summary
American Eagle Energy (AMZG) initiated with a Buy at Canaccord... FBR & Co. (FBRC) initiated with an Outperform at Barrington... KapStone (KS) initiated with an Overweight at Barclays... MercadoLibre (MELI) initiated with a Sell at Citigroup... ONEOK Partners (OKS) initiated with a Neutral at UBS... Targa Resources Partners (NGLS) initiated with a Buy at UBS... William Lyon Homes (WLH) reinstated with a Neutral at Credit Suisse... Dresser-Rand (DRC) initiated with a Buy at Gabelli... Scansource (SCSC) initiated with a Buy at Sidoti... Yelp (YELP) initiated with a Market Perform at Wells Fargo... HCA Holdings (HCA) initiated with a Buy at Monness Crespi... Community Health (CYH) initiated with a Buy at BofA/Merrill... Universal Health (UHS) initiated with a Neutral at Monness Crespi... Tenet (THC) initiated with a Neutral at Monness Crespi... LifePoint Hospitals (LPNT) initiated with a Neutral at Monness Crespi... Build-A-Bear (BBW) initiated with a Buy at Craig-Hallum... Cummins (CMI) initiated with a Buy at Argus... TriplePoint Venture (TPVG) initiated with an Outperform at Wells Fargo... Myriad Genetics (MYGN) resumed with an Underweight at JPMorgan... Apache (APA) initiated with a Buy at KLR Group.
News For AMZG;FBRC;KS;MELI;OKS;NGLS;TPVG;WLH;DRC;YELP;SCSC;CYH;HCA;UHS;THC;LPNT;BBW;CMI;MYGN;APA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 20, 2015
07:41 EDTMYGNAmerican Academy of Dermatology to hold annual meeting
Subscribe for More Information
06:16 EDTYELP2012 antitrust report calls Google harmful to market, WSJ says
Subscribe for More Information
06:11 EDTYELPYelp selloff yesterday a buying opportunity, says Wunderlich
Subscribe for More Information
06:08 EDTYELPStocks with implied volatility below IV index mean; LL YELP
Subscribe for More Information
05:17 EDTMYGNMyriad EMPATHY-P clinical study results to be highlighted at annual congress
Myriad Genetics announced that results from the EMPATHY-P clinical study of Prolaris in patients newly diagnosed with prostate cancer will be highlighted at the 30th Annual Congress of the European Association of Urology. The EMPATHY-P study evaluated the Prolaris test on 525 patient biopsy samples to determine the aggressiveness of prostate cancer in these newly diagnosed patients from five European countries including: Italy, Germany, Spain, Switzerland and the UK. The patients' biopsy samples also were evaluated using standard clinical pathology methods, which were then compared to the Prolaris test results. The EMPATHY-P data showed, overall, that the Prolaris test found 42% of the European men evaluated had a risk profile that was either lower or higher than would be expected using clinical pathology. Interestingly, this finding is consistent with the previously published U.S. Prostate Biopsy Research study, which found 51% of U.S. patients had a risk profile that differed from clinical pathology.
March 19, 2015
13:51 EDTYELPYelp weakness a buying opportunity, says Cowen
Subscribe for More Information
11:38 EDTCMIGE Marine announces Reinauer purchases two diesel engines, gearboxes
Subscribe for More Information
11:08 EDTDRCDresser-Rand drops 2% after German magazine highlights integration issues
Subscribe for More Information
11:07 EDTDRCDresser-Rand, Siemens integration not smooth, Manager Magazin says
Subscribe for More Information
10:12 EDTYELPYelp puts active after plans for critical documentary announced
Subscribe for More Information
10:05 EDTLPNTLifePoint enters into 10b5-1 trading plan
In a regulatory filing, LifePoint reports that effective March 17, it entered into a trading plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934 as amended, under which the company may repurchase its shares at times when it would not ordinarily be in the market due to the company’s trading policies or possession of material non-public information. This plan has been established pursuant to, and as part of, the company’s stock repurchase program, which is effective through October 1, of which $75M remained available as of March 16. The plan will expire on May 5, unless terminated earlier.
09:43 EDTYELPYelp falls after plans for critical documentary announced
Subscribe for More Information
March 18, 2015
10:00 EDTMELIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:04 EDTNGLSTarga Resources Partners resumed with a Market Perform at Wells Fargo
Price target range $41-$45.
06:27 EDTMELIMercadoLibre downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
March 17, 2015
10:02 EDTCYHHigh option volume stocks
High option volume stocks: NGL ARCO ENR OIL SNI ESPR CYH WIN CRZO DISH
07:18 EDTMYGNMyriad Genetics announces collaboration expansion with BioMarin
Myriad Genetics (MYGN) announced an expansion of the company's collaboration with BioMarin Pharmaceutical (BMRN). Under the expanded collaboration, BioMarin will use Myriad's myChoice HRD companion diagnostic test to prospectively identify patients with metastatic breast, ovarian and potentially other tumor types that may be sensitive to talazoparib. Financial terms were not disclosed.
March 16, 2015
16:14 EDTTPVGTriplePoint Venture declares Q1 dividend of 36c
Subscribe for More Information
16:13 EDTTPVGTriplePoint Venture reports Q4 EPS 57c, consensus 40c
Reports net asset value per share of $14.61 as of December 31, 2014.
08:01 EDTNGLSTarga Resources added to Top Picks List at UBS
UBS added Targa Resources (TRGP) to its Top Picks List as they believe the combined models of it and Targa Resources Partners (NGLS) will provide new growth opportunities, but also increased commodity exposures. As a result, UBS maintains its Buy rating but lowers its price target to $118 from $127 on Targa Resources shares.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use